-
It's Time To Consider Leveraged Healthcare ETFs
Friday, June 7, 2019 - 9:29am | 503Read More...For traders using leveraged sector exchange-traded funds, one key to successfully using these products in the short-term fashion in which they are intended is to treat leveraged ETFs as event-driven trades. Those events include earnings announcements, mergers and acquisitions headlines and, for...
-
ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy
Wednesday, June 4, 2014 - 2:08pm | 459Read More...The 2014 Annual Meeting of the American Society of Clinical Oncology (ASCO) took place in Chicago, Illinois, with meetings and presentations from May 30 to June 3. At this year's 50th Annual Meeting, more than 25,000 cancer specialists gathered to discuss research on the theme of "...
-
ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?
Wednesday, June 4, 2014 - 1:58pm | 569Read More...The 2014 Annual Meeting of the American Society of Clinical Oncology (ASCO) just wrapped up in Chicago, Illinois, with meetings and presentations from May 30 to June 3. At this year's 50th Annual Meeting, more than 25,000 cancer specialists gathered to discuss research on the theme of...
-
ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy
Wednesday, June 4, 2014 - 10:32am | 559Read More...The 2014 Annual Meeting of the American Society of Clinical Oncology (ASCO) just wrapped up in Chicago, Illinois with meetings and presentations from May 30 to June 3. At this year's 50th Annual Meeting, more than 25,000 cancer specialists gathered to discuss research on the theme of "...
-
Puts Sold on Keryx Biopharma (KERX)
Friday, July 2, 2010 - 11:24am | 122Read More...Shares of Keryx Biopharmaceuticals (NASDAQ: KERX) are higher on the session by 3.43%, currently trading at $3.62. The stock has been trading largely lower over the past three months, off from its highs near $6.70, which were reached during the ASCO conference. Options traders are selling puts on...
